Zombie Data: The silent threat to real-world data in life sciences
In the rapidly evolving world of real-world data (RWD) for life sciences and commercial...
In the rapidly evolving world of real-world data (RWD) for life sciences and commercial...
The one constant in healthcare marketing is change, particularly in four key areas: Evolving...
In recent years, there has been a shift in the pharmaceutical industry with more and more specialty...
In our series exploring the benefits, considerations and use cases for various types of real-world...
Background While the COVID-19 pandemic is behind us, the virus remains a concern that needs to be...
The healthcare industry has moved away from paper charts and file folders in favor of electronic...
The FDA recently released draft guidance that provides details on creating Diversity Action Plans...
As the industry develops increasingly complex treatments to address unmet clinical needs, it is...
Open claims and closed payer claims data are essential for understanding the status and activities...
The FDA often requires some sort of post-market surveillance for medical devices to determine the...
In the rapidly evolving world of real-world data (RWD) for life sciences and commercial applications, data provenance and data quality serve as unwavering cornerstones for actionable insights. Yet, an unsettling trend has emerged in the form of "Zomb...